/People

Hyung Chun

Investor

Partner at Foresite Capital

New Haven, Connecticut

Writes $2M – $75M checks · typically $38.5M

Find your path to Hyung

594 people in our graph can introduce you to Hyung.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Luke Bagaason to introduce you to Hyung

You →Luke · together at Foresite Capital (2021–2026) →Hyung

Ask Jamie Chen to introduce you to Hyung

You →Jamie · 4 people · together at Foresite Capital →Hyung

Ask Sam Okafor to introduce you to Hyung

You →Sam · 4 people · together at National Institutes of Health →Hyung

Sign up to find every way you can get introduced to Hyung

  • Your email: the people you already email who know Hyung
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Hyung
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Hyung Chun is a physician scientist who joined Foresite Capital in 2021, where he evaluates investment opportunities in private and public biotech companies. Before Foresite, he was a tenured faculty member at Yale School of Medicine, where he held roles including Co-Director of the Yale Cardiovascular Research Center, and remains an adjunct faculty member. He earned an A.B. in Biochemical Sciences from Harvard College and an M.D. from Johns Hopkins, and completed his residency and cardiovascular fellowship at Stanford.

Invests in

Biotech

Experience

  1. Foresite CapitalPartnercurrent2021 — present
  2. Stanford University School of MedicineAdjunct Professorcurrent2023 — present
  3. Yale University School of MedicineAdjunct Associate Professorcurrent2022 — presentNew Haven, Connecticut, United States
  4. Yale University School of MedicineAssociate Professor of Medicine and Pathology with Tenure2019 — 2022
  5. Yale University School of MedicineCo-Director, Yale Cardiovascular Research Center2021
  6. Yale University School of MedicineAssociate Professor of Medicine2015 — 2019
  7. Yale University School of MedicineAssistant Professor2009 — 2015
  8. Latigo Biotherapeutics, Inc.Board Membercurrent2022 — present
  9. Odyssey TherapeuticsBoard Observer2021 — 2024
  10. Stanford University School of MedicineChief Cardiology Fellow2008 — 2009
  11. Stanford University School of MedicineCardiology Fellow2004 — 2009
  12. Stanford University School of MedicineInternal Medicine Resident2002 — 2004
  13. National Institutes of HealthHHMI/NIH Research Scholar1999 — 2001

Skills & more

Higher EducationTeaching2University TeachingResearch4Statistics3Science4Student AffairsMolecular Biology7Public Speaking1Curriculum DesignQualitative ResearchCurriculum Development
+6 moreGrant WritingCell BiologyTutoringClinical ResearchClinical TrialsMedical Education

Languages Korean

  • ABIM Cardiovascular Medicine — American Board of Internal Medicine

From Hyung's professional profile.

Investments

Board seats

IndomoLatigo BioModal Therapeutics

Investor

IndomoLatigo Bio

Sources: the firm's website · curated public sources.

Colleagues at Foresite Capital

Network1

Investors connected to Hyung in public investor directories — a warm-intro map.

Frequently asked questions

Who is Hyung Chun?
Hyung Chun is a physician scientist who joined Foresite Capital in 2021, where he evaluates investment opportunities in private and public biotech companies. Before Foresite, he was a tenured faculty member at Yale School of Medicine, where he held roles including Co-Director of the Yale Cardiovascular Research Center, and remains an adjunct faculty member. He earned an A.B. in Biochemical Sciences from Harvard College and an M.D. from Johns Hopkins, and completed his residency and cardiovascular fellowship at Stanford.
Where does Hyung Chun work?
Hyung Chun is Partner at Foresite Capital.
What does Hyung Chun invest in?
Hyung Chun invests in Biotech.
What check size does Hyung Chun write?
Hyung Chun typically writes checks of $2M – $75M.
What boards does Hyung Chun sit on?
Hyung Chun holds tracked board seats at Indomo, Latigo Bio, Modal Therapeutics.
What companies has Hyung Chun invested in?
Investments tracked here include Indomo, Latigo Bio.
Where did Hyung Chun go to school?
Hyung Chun studied at The Johns Hopkins University School of Medicine (Doctor of Medicine (MD)); Harvard University (AB, Biochemical Sciences).

Same school

Shared employers